ArticleProceedings of SPIE--the International Society for Optical Engineering2024
Fluoroscopic Procedure-Room Scatter-Dose Reduction Using a Region-of-Interest (ROI) Attenuator.
Article in Proceedings of SPIE--the International Society for Optical Engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
During fluoroscopically-guided interventional (FGI) procedures, dose to the patient as well as the scatter dose to staff can be high. However, a significant dose reduction can be possible by using a region-of-interest (ROI) attenuator that reduces the x-ray intensity in the peripheral x-ray field while providing full field of view imaging. In this work, we investigated the magnitude of scatter dose reduction to staff made possible by using an ROI attenuator composed of 0.7 mm Cu with a central circular hole that projected a 5.4 cm ROI onto a Kyoto anthropomorphic phantom in the head, chest, and abdomen regions. A 150-cc ionization chamber was placed on a stand at a height of 150 cm (eye level) from the floor and 25 cm and 50 cm lateral distance from the gantry isocenter in a direction perpendicular to the table centerline to measure scatter dose at different positions along the length of the table. Scatter dose per entrance air kerma (mGy/Gy) was measured with and without the ROI attenuator and the percent scatter reduction for the ROI attenuator was determined as a function of staff positions, beam energy and gantry angulation. For head imaging, the measured percent dose reduction was 50%-65% and, for chest and abdomen imaging, the scatter dose reduction was 63%-72% at 50 cm lateral distance when using this ROI attenuator with about 20% beam transmission at 80 kVp. Overall, a considerable reduction of scattered radiation in the interventional room can be realized using an ROI attenuator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.